Clinical trial
The Plenaxis® Experience Study
NCT00103623
Study timeline
Study start (unknown)2004-06-01Date precision: month
Registry last updated2006-09-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
PlenaxisDRUG
Sponsors & collaborators
PRAECIS Pharmaceuticals Inc.lead sponsor
Mapped research locations
ChicagoIllinois, United States2OcalaFlorida, United States2Pembroke PinesFlorida, United States2PhiladelphiaPennsylvania, United States1SeattleWashington, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1TampaFlorida, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00103623 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.